Clinical Trial Update: A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the dapivirine vaginal ring for HIV prevention in Africa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine vaginal ring (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 3 | Status: WITHDRAWN